Nab-Sirolimus
High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma
Aadi Bioscience, Inc.Phase 2
—
Rating in progress
Nab-Sirolimus in High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Dormant